Skip to main content
. 2021 Oct 11;13(20):5085. doi: 10.3390/cancers13205085

Table 1.

Studies comparing data about lymph node metastasis in thymic tumors over the last 20 years.

Author Year Country P/R N pts Intentional Lymphadenectomy n LN Dissected (Mean) Type of Tumor (%) Lymph Node Metastasis (%) Metastatic Stations (%)
T TC NETT Overall T TC NETT N1 N2
Kondo [3] 2003 Japan R 1320 No - 82.8 14.1 3.1 6.7 1.8 26.8 27.5 - -
Park [4] 2013 Korea R 29 Yes 9.4 - 100 - 20.8 - 20.8 - - -
Weissferdt [20] 2012 USA R 33 Yes - - 100 - 37 - 37 - 16.7 20
Weksler [6] 2015 USA R 229 No 3 - 76.9 23.1 40.2 - 33.5 62.3 - -
Weksler [7] 2015 USA R 442 No 2 100 - - 13.3 13.3 - - - -
Hwang [8] 2016 Korea R 131 Yes 10.3 75.6 24.4 - 9.9 5.1 25 - 4.6 5.4
Gu [2] 2017 China R 1617 No - 81 16.4 2.6 2.2 0.5 7.9 16.7 - -
Zhao [21] 2017 China R 116 Yes 2.3 (TC)
1.8 (NETT)
- 81.8 18.1 53.4 - 48.4 76.2 50 35.5
Fang [22] 2018 China P 275 Yes 4.9 88.4 8.7 2.9 5.5 2.1 25 50 4.7 2.9
Hwang [23] 2018 Korea R 446 Yes 8.9 66.8 33.2 - 15.0 6.7 31.8 - 9.6 5.4
Wen [24] 2018 China R 3947 No - 70.6 21.9 7.4 6.1 11.1 33.0 57.0 - -
Cheufou [25] 2019 Germany R 53 No 3.5 - 81.1 18.9 30.2 - 24.5 5.6 20.8 9.4
Song [26] 2019 China R 363 No - - 66.3 33.7 34.3 - - - - -
Wang [27] 2020 USA R 398 Yes 1–3 (46%)
>4 (47%)
- 78.6 21.4 36.2 - 30 58.8 - -
Clermidy [28] 2021 France R 54 Yes 3.9 100 - - 5.6 5.6 - - 0 6.1

P/R: prospective/retrospective; T: thymoma; TC: thymic carcinoma; NETT: thymic neuroendocrine tumor; LN: lymph node.